- Home
- PTGX vs FOXF Comparison
PTGX vs FOXF Comparison
Compare PTGX & FOXF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- FOXF
- Stock Information
- Founded
- PTGX 2006
- FOXF 2007
- Country
- PTGX United States
- FOXF United States
- Employees
- PTGX N/A
- FOXF N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- FOXF Motor Vehicles
- Sector
- PTGX Health Care
- FOXF Consumer Discretionary
- Exchange
- PTGX Nasdaq
- FOXF Nasdaq
- Market Cap
- PTGX 2.9B
- FOXF N/A
- IPO Year
- PTGX 2016
- FOXF N/A
- Fundamental
- Price
- PTGX $55.06
- FOXF $25.94
- Analyst Decision
- PTGX Strong Buy
- FOXF Buy
- Analyst Count
- PTGX 9
- FOXF 7
- Target Price
- PTGX $67.11
- FOXF $36.43
- AVG Volume (30 Days)
- PTGX 1.0M
- FOXF 554.6K
- Earning Date
- PTGX 08-05-2025
- FOXF 07-31-2025
- Dividend Yield
- PTGX N/A
- FOXF N/A
- EPS Growth
- PTGX N/A
- FOXF N/A
- EPS
- PTGX 0.86
- FOXF N/A
- Revenue
- PTGX $207,801,000.00
- FOXF $1,415,479,000.00
- Revenue This Year
- PTGX N/A
- FOXF $5.17
- Revenue Next Year
- PTGX $47.15
- FOXF $6.34
- P/E Ratio
- PTGX $64.57
- FOXF N/A
- Revenue Growth
- PTGX N/A
- FOXF 1.26
- 52 Week Low
- PTGX $32.50
- FOXF $17.95
- 52 Week High
- PTGX $60.60
- FOXF $54.86
- Technical
- Relative Strength Index (RSI)
- PTGX 64.63
- FOXF 55.76
- Support Level
- PTGX $52.16
- FOXF $24.42
- Resistance Level
- PTGX $57.18
- FOXF $25.22
- Average True Range (ATR)
- PTGX 1.85
- FOXF 0.82
- MACD
- PTGX -0.27
- FOXF -0.14
- Stochastic Oscillator
- PTGX 55.14
- FOXF 48.39
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.